Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04655469 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personal Health Train for Radiation Oncology in India and The Netherlands

Study acronym: TRAIN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion date: Nov 1, 2024 to Dec 31, 2025v5
  2. Primary completion date: Dec 31, 2023 to May 15, 2024 Completion date: Feb 1, 2024 to Nov 1, 2024v4 Show 1 more changeShow less
    • Completion date: Feb 1, 2024 to Nov 1, 2024
  3. Primary completion date: Dec 31, 2022 to Dec 31, 2023v3
  4. Primary completion date: Apr 10, 2022 to Dec 31, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary and general objective of this protocol as the current standard of care is to improve the quality of radiotherapy for HNC patients. This will ultimately be achieved by optimizing locoregional tumour control and overall survival and by reducing radiation-induced side effects. It will also allow the assessment of the effects of newly introduced radiation technology (e.g. proton therapy) for this particular group of patients. The clinical introduction of this standard follow-up program (SFP) will allow for a systematic and broad scale quality improvement cycle for HNC patients treated with radiotherapy.
Trial Details
NCT Number NCT04655469
Lead Sponsor Maastricht Radiation Oncology
Conditions Head and Neck Carcinoma
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov